Perforation of tympanic membrane

H8_PERFORATION

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H72 Hospital discharge: ICD-9 — 3842 Cause of death: ICD-10 — H72 Cause of death: ICD-9 — 3842 2 out of 7 registries used, show all original rules.	4120
4. Check minimum number of events None	4120
5. Include endpoints None	4120
6. Filter based on genotype QC (FinnGen only)	4120

Control definitions (FinnGen only)

Control exclude: H8_MIDDLEMASTOID

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H65-H75
Name in latin: Perforatio membranae tympanicae

NAME	H8_PERFORATION
CONTROL_EXCLUDE	H8_MIDDLEMASTOID
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H72
HD_ICD_9	3842
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H72
COD_ICD_9	3842
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Perforation of tympanic membrane based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	39492	18838	20408
Only index persons	35816	17317	18499
Unadjusted period prevalence (%)
Whole population	0.55	0.54	0.57
Only index persons	0.67	0.64	0.71
Median age at first event (years)
Whole population	38.96	43.48	34.79
Only index persons	39.96	44.51	35.70

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4120	2297	1823
Unadjusted period prevalence (%)	0.79	0.78	0.80
Median age at first event (years)	50.83	48.08	54.30

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3676: Matched controls
36762

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

UDC00

NOMESCO Finland

Ear microscopy

16.5

323.0

1178

1020

H66.9

ICD-10 Finland

Otitis media, unspecified

12.0

323.0

687

690

3842A

ICD-9 Finland

Other disorders of tympanic membrane, Perforation of tympanic membrane

+∞

323.0

392

H65.3

ICD-10 Finland

Chronic mucoid otitis media

637.4

323.0

592

4141

FHL

Myringoplasty (also for reasons other than inflammation)

2023.7

323.0

349

H72.2

ICD-10 Finland

Other marginal perforations of tympanic membrane

+∞

323.0

470

Z01.1

ICD-10 Finland

Examination of ears and hearing

7.1

323.0

1256

2518

DFF00

NOMESCO Finland

Pure tone audiometry

7.8

323.0

873

1417

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

305.0

323.0

546

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

333.9

323.0

681

H66.0

ICD-10 Finland

Acute suppurative otitis media

21.7

323.0

1017

637

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

9222.4

323.0

2754

H71

ICD-10 Finland

Cholesteatoma of middle ear

1299.6

323.0

353

DCD00

NOMESCO Finland

Myringoplasty

6176.4

323.0

952

H65.2

ICD-10 Finland

Chronic serous otitis media

547.4

308.8

303

H72.8

ICD-10 Finland

Other perforations of tympanic membrane

285.8

262.4

265

DC1AD

NOMESCO Finland

Temporalbone CT

59.3

254.2

300

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

45.3

238.8

296

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

134.9

214.0

228

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

23.7

203.7

297

136

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

102.7

202.7

222

H60.9

ICD-10 Finland

Otitis externa, unspecified

6.5

201.5

570

1007

4122

FHL

Tympanostomy (tympanic tube)

102.9

178.0

195

3812A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media

+∞

171.2

163

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.6

165.8

2205

13397

H72.1

ICD-10 Finland

Attic perforation of tympanic membrane

1691.9

162.7

157

DCD10

NOMESCO Finland

Tympanoplasty

398.8

154.4

154

H74.1

ICD-10 Finland

Adhesive middle ear disease

+∞

153.2

146

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

+∞

153.2

146

H65.0

ICD-10 Finland

Acute serous otitis media

27.9

152.2

211

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.7

144.1

1317

6294

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

3.3

140.1

847

3077

DCW99

NOMESCO Finland

Other operation on eardrum and middle ear

709.5

139.8

137

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

83.5

135.4

152

H72

ICD-10 Finland

Perforation of tympanic membrane

198.5

129.5

134

TDA90

NOMESCO Finland

Removal wax from ear

17.2

128.3

208

128

H60.3

ICD-10 Finland

Other infective otitis externa

11.1

128.3

252

241

DCA40

NOMESCO Finland

Fat patching or other similar technique without opening of tympanic membrane

1271.0

126.8

123

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

124.4

122.9

132

H70.1

ICD-10 Finland

Chronic mastoiditis

+∞

119.4

114

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

15.1

114.9

196

137

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

+∞

112.0

107

H60.8

ICD-10 Finland

Other otitis externa

8.0

107.5

256

342

H04

ICPC

Ear discharge

6.8

105.1

278

434

DGW00

NOMESCO Finland

Dilatation of eustachian tube

1047.5

104.8

102

H01

ICPC

Ear pain/earache

3.4

104.3

583

1957

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

22.6

103.4

152

S02CA02

ATC

flumetasone and antiinfectives; otic

4.8

102.6

370

840

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

15.3

92.9

157

107

J01CA04

ATC

amoxicillin; systemic

2.4

92.3

3063

24913

S09.2

ICD-10 Finland

Traumatic rupture of ear drum

58.5

91.6

108

H66.1

ICD-10 Finland

Chronic tubotympanic suppurative otitis media

102.8

91.4

100

38402

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita

+∞

88.9

H73.1

ICD-10 Finland

Chronic myringitis

+∞

85.7

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

432.4

85.4

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

8.1

85.0

199

258

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

5.8

84.8

255

469

3821A

ICD-9 Finland

Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media

+∞

83.6

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

4.0

80.9

354

962

H66

ICD-10 Finland

Suppurative and unspecified otitis media

7.0

80.5

207

309

DBD20

NOMESCO Finland

Plastic repair of external auditory canal

50.1

76.9

DEB25

NOMESCO Finland

Attico-antro-mastoidectomy and tympanoplasty

+∞

76.3

EMB30

NOMESCO Finland

Adenotomy

8.4

74.3

169

209

Z97.4

ICD-10 Finland

Presence of external hearing-aid

4.5

73.4

277

653

DEA10

NOMESCO Finland

Attico-antrotomy

+∞

73.2

DFF15

NOMESCO Finland

Speech audiometry

4.5

70.0

265

626

H60

ICD-10 Finland

Otitis externa

4.3

69.0

271

664

H29

ICPC

Ear symptom/complaint other

2.8

68.1

479

1844

J01DA01

ATC

[U] cefalexin; systemic

1.8

68.0

2272

17163

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.5

67.2

342

1049

DEB20

NOMESCO Finland

Attico-antro-mastoidectomy and tympanotomy

+∞

65.8

J01DB01

ATC

cefalexin; oral

2.0

65.4

2979

24934

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

+∞

64.8

H92.0

ICD-10 Finland

Otalgia

4.0

63.6

276

740

H74.2

ICD-10 Finland

Discontinuity and dislocation of ear ossicles

618.3

62.0

H61.2

ICD-10 Finland

Impacted cerumen

3.5

61.0

303

910

DEB10

NOMESCO Finland

Attico-antro-mastoidectomy

+∞

60.6

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

4.2

59.6

238

591

38401

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva

+∞

59.5

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

16.4

58.9

H92.1

ICD-10 Finland

Otorrhoea

56.0

55.8

Z3229

NOMESCO Finland

Other healthcare associate professional

2.7

54.1

402

1587

4451

FHL

Guitar cutting

5.5

53.6

164

307

R01AD08

ATC

fluticasone; nasal

1.9

53.2

1043

6414

38210

ICD-8 Finland

Chronic otitis media with mastoiditis

+∞

51.2

J01MA02

ATC

ciprofloxacin; systemic

1.7

50.5

1346

9122

R01AD09

ATC

mometasone; nasal

1.7

48.8

1560

11125

H02

ICPC

Hearing complaint

2.4

47.8

460

2091

38199

ICD-8 Finland

Otitis media without mention of mastoiditis, Unspecified

+∞

47.0

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.9

46.7

202

539

H77

ICPC

Perforation ear drum

70.8

43.1

J01FA10

ATC

azithromycin; systemic

1.6

42.6

2006

15680

H73.0

ICD-10 Finland

Acute myringitis

28.0

42.5

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

4.4

42.1

160

379

J01DC02

ATC

cefuroxime; systemic

3.0

41.2

257

905

DAX08

NOMESCO Finland

Fitting of hearing aid

3.5

39.9

194

571

38700

ICD-8 Finland

Other disease of ear and mastoid process, Cholesteatoma of ear

+∞

39.6

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

9.6

39.6

H60.4

ICD-10 Finland

Cholesteatoma of external ear

29.8

39.6

H02AB06

ATC

prednisolone; systemic

1.6

37.7

1569

11736

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

37.6

959

6288

TDC10

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

+∞

37.6

ZXA10

NOMESCO Finland

Bilateral

1.9

36.5

662

3885

J01DA06

ATC

[U] cefuroxime; systemic

2.0

35.1

528

2891

DEB30

NOMESCO Finland

Radical mastoidectomy

350.5

35.0

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.5

34.3

293

1243

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

3.9

34.0

146

388

WX110

NOMESCO Finland

Local anesthesy

1.5

33.6

2368

19838

4145

FHL

Tympanomastoidectomy, includes possible tympanoplasty

+∞

33.4

ZXA05

NOMESCO Finland

Left side

1.7

33.3

868

5690

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

3.3

32.8

173

543

N02BE01

ATC

paracetamol; systemic, rectal

1.6

32.5

2949

26158

H69.0

ICD-10 Finland

Patulous Eustachian tube

25.3

32.3

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

2.2

31.3

335

1588

J01DA08

ATC

[U] cefaclor; oral

2.0

30.8

437

2334

J01FA09

ATC

clarithromycin; systemic

1.6

30.6

1047

7356

R5120

NOMESCO Finland

Preparation of an aid

3.9

30.5

129

338

J35.2

ICD-10 Finland

Hypertrophy of adenoids

5.2

30.2

185

ZXD20

NOMESCO Finland

Day surgery

1.9

29.9

469

2600

1450

FHL

Otomicroscopy

15.5

29.9

UDC10

NOMESCO Finland

Tympanoscopy

304.8

29.8

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

29.5

972

6751

H70

ICPC

Otitis externa

4.3

29.4

112

267

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

+∞

29.2

H71

ICPC

Acute otitis media/myringitis

6.3

29.2

128

ZXA00

NOMESCO Finland

Right side

1.6

28.7

895

6120

4144

FHL

Mastoidectomy or aticomastoidectomy

+∞

28.2

H66.2

ICD-10 Finland

Chronic atticoantral suppurative otitis media

+∞

28.2

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

28.1

897

6167

H02AB04

ATC

methylprednisolone; systemic

1.9

27.9

487

2799

DCW00

NOMESCO Finland

Removal of ventilating tube from tympanic membrane

283.6

27.8

4121

FHL

Tympanic puncture or parasentosis in general anesthesia or operating room

13.5

27.7

H90.8

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unspecified

11.2

27.5

H91.9

ICD-10 Finland

Hearing loss, unspecified

2.9

27.0

171

607

R01AD12

ATC

fluticasone furoate; nasal

1.6

26.9

957

6746

J01FF01

ATC

clindamycin; systemic

1.6

26.7

886

6139

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

26.3

1374

10550

38400

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) acuta

+∞

26.1

3853A

ICD-9 Finland

Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid

+∞

26.1

H95.1

ICD-10 Finland

Other disorders following mastoidectomy

262.4

25.7

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

25.6

689

4515

SPAT1043

SPAT

Audiometry

2.0

25.4

356

1887

H13

ICPC

Plugged feeling ear

1.7

25.4

583

3653

Z96.2

ICD-10 Finland

Presence of otological and audiological implants

70.4

24.8

DCA30

NOMESCO Finland

Exploration of middle ear

70.4

24.8

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

24.7

571

3579

ZZG00

NOMESCO Finland

Graft of cartilage

43.1

24.6

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

3.6

24.1

112

320

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

3.5

23.7

115

340

H70.0

ICD-10 Finland

Acute mastoiditis

241.5

23.7

R03AC02

ATC

salbutamol; inhalant

1.4

23.6

1700

13818

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.5

23.1

195

819

1451

FHL

Otomicroscopy and paper place

+∞

22.9

J33.8

ICD-10 Finland

Other polyp of sinus

4.0

22.9

242

J01AA02

ATC

doxycycline; systemic

1.4

22.4

2514

22095

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

22.2

1163

8855

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

21.7

714

4902

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

21.7

1238

9580

H73.8

ICD-10 Finland

Other specified disorders of tympanic membrane

115.7

21.6

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

21.5

552

3551

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

21.4

380

2188

4150

FHL

Tympanoplasty (including for reasons other than inflammation)

60.4

20.9

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

20.1

1402

11216

N02AX02

ATC

tramadol; systemic, rectal

1.4

20.0

1286

10135

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

19.7

638

4350

74900

ICD-8 Finland

Cleft palate and cleft lip, Cleft palate

29.1

19.6

H95.0

ICD-10 Finland

Recurrent cholesteatoma of postmastoidectomy cavity

201.0

19.6

A02BC02

ATC

pantoprazole; systemic

1.4

19.3

2043

17509

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

19.3

667

4620

J32.4

ICD-10 Finland

Chronic pansinusitis

4.6

19.2

148

ZZF00

NOMESCO Finland

Graft of adipose tissue

6.6

19.2

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

18.9

1034

7885

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

18.8

186

847

H74.0

ICD-10 Finland

Tympanosclerosis

+∞

18.8

Q35.1

ICD-10 Finland

Cleft hard palate

27.9

18.7

H95.8

ICD-10 Finland

Other postprocedural disorders of ear and mastoid process

190.9

18.5

38798

ICD-8 Finland

Other disease of ear and mastoid process, Alii definiti

38.6

18.5

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

18.3

873

6473

SPAT1263

SPAT

Sampling

1.4

17.9

1374

11105

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

17.9

200

966

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.7

17.8

127

489

SPAT1301

SPAT

No procedures

1.4

17.7

1012

7758

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.9

17.6

107

374

4742A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Adenoid vegetations

3.9

17.5

192

ZXC10

NOMESCO Finland

Use of laser

3.3

17.4

276

UDM02

NOMESCO Finland

Sinoscopy

3.3

17.3

266

DEB00

NOMESCO Finland

Cortical mastoidectomy

42.2

17.3

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

17.3

232

1206

R01AD11

ATC

triamcinolone; nasal

1.8

17.2

284

1592

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

17.2

644

4527

R4135

NOMESCO Finland

Rehabilitation for hearing problems

4.0

17.0

177

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

17.0

583

4015

S02AA03

ATC

boric acid; otic

5.4

17.0

J01DC04

ATC

cefaclor; oral

4.3

16.9

145

H69.8

ICD-10 Finland

Other specified disorders of Eustachian tube

25.7

16.9

H61.8

ICD-10 Finland

Other specified disorders of external ear

4.9

16.9

114

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

3.3

16.5

265

DDD05

NOMESCO Finland

Plastic repair of ossicular chain

170.7

16.5

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

16.4

1689

14253

S18

ICPC

Laceration/cut

1.4

16.3

1283

10366

R42

ICD-10 Finland

Dizziness and giddiness

1.5

16.3

643

4569

J34.2

ICD-10 Finland

Deviated nasal septum

2.2

16.2

166

770

K02.1

ICD-10 Finland

Caries of dentine

1.3

16.0

1812

15485

L08

ICPC

Shoulder symptom/complaint

1.5

15.8

554

3833

ZXE00

NOMESCO Finland

One hour or less

1.4

15.8

1233

9939

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

15.8

582

4072

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

15.7

1092

8633

DCB00

NOMESCO Finland

Excision of lesion of middle ear

160.6

15.5

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

15.4

1283

10440

J01MA12

ATC

levofloxacin; systemic

1.5

15.2

542

3762

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

15.2

890

6822

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

15.1

393

2526

WX290

NOMESCO Finland

Other blockade of nerve

1.3

15.1

1358

11176

A02BC01

ATC

omeprazole; systemic

1.4

15.0

813

6138

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

15.0

299

1783

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

15.0

1501

12552

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

14.9

273

1584

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

14.8

310

1879

N06AX11

ATC

mirtazapine; oral

1.4

14.3

933

7277

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

14.1

119

503

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

14.0

1391

11581

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

14.0

2277

20337

SPAT1044

SPAT

Tympanometry

2.9

13.9

283

R74

ICPC

Upper respiratory infection acute

1.4

13.7

861

6659

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

13.7

1120

9049

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

13.6

1690

14504

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

13.6

1102

8882

R03BA05

ATC

fluticasone; inhalant

1.5

13.6

547

3891

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

13.6

404

2682

H73.9

ICD-10 Finland

Disorder of tympanic membrane, unspecified

75.4

13.6

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

13.6

622

4540

3824A

ICD-9 Finland

Suppurative and unspecified otitis media, Unspecified suppurative otitis media

+∞

13.5

DCA00

NOMESCO Finland

Biopsy of tympanic membrane or middle ear

+∞

13.5

DEB35

NOMESCO Finland

Radical mastoidectomy with tympanoplasty

+∞

13.5

J02AC01

ATC

fluconazole; systemic

1.3

13.5

1151

9349

H60.1

ICD-10 Finland

Cellulitis of external ear

4.2

13.5

124

R01AD05

ATC

budesonide; nasal

1.8

13.5

238

1365

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

13.5

1767

15269

AA1AD

NOMESCO Finland

CT of head and brain

1.4

13.5

674

5002

4129

FHL

Other measure in this category

140.5

13.5

H60.0

ICD-10 Finland

Abscess of external ear

7.4

13.4

DBB00

NOMESCO Finland

Excision of lesion of external auditory canal

12.8

13.4

WX704

NOMESCO Finland

Intubation

1.8

13.4

215

1197

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

13.3

416

2798

R51.80

ICD-10 Finland

Headache

1.5

13.3

441

3008

J35.1

ICD-10 Finland

Hypertrophy of tonsils

3.1

13.2

231

N07CA01

ATC

betahistine; oral

1.8

13.1

209

1160

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

13.1

267

1602

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

13.1

522

3704

SPAT1153

SPAT

Removal of sutures

1.4

12.9

944

7476

H80.9

ICD-10 Finland

Otosclerosis, unspecified

4.8

12.9

H90.2

ICD-10 Finland

Conductive hearing loss, unspecified

7.4

12.9

DCB10

NOMESCO Finland

Freeing of adhesions of middle ear

50.2

12.8

SPAT1260

SPAT

Consultation of another employee

1.5

12.8

549

3951

SPAT1312

SPAT

General health counselling

1.3

12.8

1016

8150

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

12.8

828

6429

R06AE07

ATC

cetirizine; oral

1.3

12.8

1329

11093

DHB20

NOMESCO Finland

Polypectomy of internal nose

3.6

12.8

156

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

12.7

714

5412

H80.0

ICD-10 Finland

Otosclerosis involving oval window, nonobliterative

4.8

12.5

4147

FHL

Radical surgery, cavity filling and middle ear and / or eardrum plastic

+∞

12.5

4143

FHL

Atticotomy or atticoanthromy through the ear canal

+∞

12.5

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

12.5

504

3583

R03DC03

ATC

montelukast; oral

1.5

12.5

467

3271

H74.4

ICD-10 Finland

Polyp of middle ear

130.4

12.4

SPAT1310

SPAT

Counselling related to known health issue

1.3

12.4

995

7990

WX400

NOMESCO Finland

Inhalation anesthesy

2.1

12.3

141

690

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

12.3

2249

20215

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

12.1

2071

18430

4741B

ICD-9 Finland

Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PHARYNGICAE]

3.8

12.0

134

SPAT1254

SPAT

Administration of medicine

1.5

11.9

456

3204

7490A

ICD-9 Finland

Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS COMPLETA]

46.8

11.9

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

11.9

191

1065

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

11.7

764

5929

H61.3

ICD-10 Finland

Acquired stenosis of external ear canal

9.6

11.7

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

11.7

1157

9564

P01AB01

ATC

metronidazole; oral, rectal

1.3

11.6

1144

9445

T16

ICD-10 Finland

Foreign body in ear

4.6

11.5

A02BC03

ATC

lansoprazole; oral

1.3

11.5

840

6635

3811A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic serous otitis media

+∞

11.5

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

11.5

637

4809

4151

FHL

Reoperation for chronic otitis media

120.4

11.4

DC1AA

NOMESCO Finland

Temporalbone X-ray examination

120.4

11.4

J01FA06

ATC

roxithromycin; oral

1.3

11.4

1184

9839

J01CA02

ATC

pivampicillin; oral

2.3

11.3

104

462

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

11.3

962

7775

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

11.2

754

5874

EBA00

NOMESCO Finland

Extraction of tooth

1.3

11.2

1014

8263

L15

ICPC

Knee symptom/complaint

1.4

11.2

604

4532

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

11.2

174

960

WX002

NOMESCO Finland

Sedation and analgesia

1.4

11.0

563

4185

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

11.0

547

4047

A07AA02

ATC

nystatin; oral

1.8

10.8

171

950

ZYC03

NOMESCO Finland

Remote contact, text-based

5.0

10.7

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

10.7

362

2476

DEE00

NOMESCO Finland

Osseous fixation of hearing aid

60.2

10.6

DDA00

NOMESCO Finland

Stapedotomy

5.0

10.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

10.6

304

2003

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

10.6

385

2677

M31.3

ICD-10 Finland

Wegener granulomatosis

7.0

10.5

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

10.5

204

1208

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

10.5

409

2883

H70.9

ICD-10 Finland

Mastoiditis, unspecified

+∞

10.4

EMB10

NOMESCO Finland

Tonsillectomy

1.8

10.4

173

978

H27

ICPC

Fear of ear disease

3.6

10.4

126

H65

ICD-10 Finland

Nonsuppurative otitis media

4.8

10.3

Q37.1

ICD-10 Finland

Cleft hard palate with unilateral cleft lip

16.1

10.3

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

10.3

214

1295

J01MA14

ATC

moxifloxacin; systemic

1.6

10.3

245

1539

N05BA04

ATC

oxazepam; oral

1.3

10.2

713

5575

DC1BD

NOMESCO Finland

Temporal bone extensive CT

23.4

10.2

N05AH04

ATC

quetiapine; oral

1.4

10.2

482

3530

M79.6

ICD-10 Finland

Pain in limb

1.3

10.1

1030

8510

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

10.1

457

3319

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

10.0

274

1782

SPAT1229

SPAT

Assessment of need for aid

1.7

10.0

220

1352

D07AC01

ATC

betamethasone; topical

1.3

10.0

972

7977

J20

ICD-10 Finland

Acute bronchitis

1.6

10.0

267

1727

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

4.4

10.0

R06.0

ICD-10 Finland

Dyspnoea

1.3

10.0

688

5370

4226

FHL

Posterior radical surgery and possible etmoidectomy

4.6

10.0

H74

ICPC

Chronic otitis media

40.2

10.0

G44.2

ICD-10 Finland

Tension-type headache

1.5

9.9

359

2491

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.8

9.9

172

986

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

9.9

823

6608

R03BA02

ATC

budesonide; inhalant

1.4

9.8

498

3695

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

9.8

478

3520

R01AD01

ATC

beclometasone; nasal

1.4

9.8

418

3004

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

4.1

9.7

A06AD11

ATC

lactulose; oral

1.5

9.7

379

2674

R06AX13

ATC

loratadine; oral

1.4

9.7

429

3100

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

9.7

681

5329

A03

ICPC

Fever

1.4

9.7

475

3501

8726A

ICD-9 Finland

Open wound of ear, Other specified parts of ear, without mention of complication[VULNUS MEMBRANAE TYMPANI, NON COMPLICATUM]

55.1

9.6

WZA90

NOMESCO Finland

Other doctors statement

1.3

9.6

690

5413

4222

FHL

Endonasal etmoidectomy

4.2

9.6

A02BC05

ATC

esomeprazole; systemic

1.3

9.6

1149

9679

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

9.6

376

2655

R96

ICPC

Asthma

1.6

9.5

244

1564

M25.5

ICD-10 Finland

Pain in joint

1.3

9.5

792

6354

L28

ICPC

Limited function/disability (L)

1.4

9.5

417

3011

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

9.5

842

6819

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

9.4

1187

10056

DBW99

NOMESCO Finland

Other operation on external auditory canal

100.3

9.4

H62.2*B36.9

ICD-10 Finland

Otomycosis NOS

+∞

9.4

Z97.8

ICD-10 Finland

Presence of other specified devices

5.8

9.3

M01AE02

ATC

naproxen; oral, rectal

1.2

9.3

1734

15373

R02

ICPC

Shortness of breath/dyspnoea

1.5

9.2

328

2265

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

3.3

9.2

139

L03

ICPC

Low back symptom/complaint

1.3

9.2

674

5309

ZZC00

NOMESCO Finland

Graft of fascia

13.7

9.2

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

9.1

364

2580

WX720

NOMESCO Finland

Own respiration

2.0

9.1

110

555

H69.9

ICD-10 Finland

Eustachian tube disorder, unspecified

8.3

9.0

X58

ICD-10 Finland

Exposure to other specified factors

1.4

9.0

397

2865

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

9.0

134

728

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

9.0

350

2465

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

3.0

9.0

170

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

8.9

2988

28285

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

8.9

880

7226

A02BA02

ATC

ranitidine; systemic

1.4

8.8

534

4076

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

2.4

8.8

292

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

3.1

8.7

145

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

8.7

120

634

R03AC03

ATC

terbutaline; inhalant

1.4

8.7

381

2745

L17

ICPC

Foot/toe symptom/complaint

1.3

8.7

707

5643

H62.2*B44.8

ICD-10 Finland

Otitis externa in aspergillosis

50.1

8.7

H02AB07

ATC

prednisone; oral

1.4

8.7

391

2837

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

8.6

980

8183

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

8.6

125

677

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

8.5

1232

10578

H93.1

ICD-10 Finland

Tinnitus

1.7

8.5

177

1071

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

3.3

8.5

121

H74.3

ICD-10 Finland

Other acquired abnormalities of ear ossicles

90.2

8.4

4362

FHL

Nozzle reconstruction

90.2

8.4

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.4

8.4

358

2570

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

8.3

400

2931

M03BX02

ATC

tizanidine; oral

1.2

8.3

1816

16298

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

8.3

200

1262

3851A

ICD-9 Finland

Other disorders of middle ear and mastoid, Adhesive middle ear disease

+∞

8.3

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

8.2

248

1654

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

8.2

627

4963

N06AX16

ATC

venlafaxine; oral

1.4

8.1

373

2714

SPAT1211

SPAT

Application of soft bandage

1.5

8.1

254

1709

H72

ICPC

Serous otitis media

22.1

8.0

H60.2

ICD-10 Finland

Malignant otitis externa

22.1

8.0

G47.3

ICD-10 Finland

Sleep apnoea

1.3

8.0

542

4210

R53

ICD-10 Finland

Malaise and fatigue

1.3

8.0

579

4543

R06AE09

ATC

levocetirizine; oral

1.4

8.0

404

2993

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

7.9

131

740

WX402

NOMESCO Finland

General anaesthesia

1.4

7.9

459

3478

N03AX16

ATC

pregabalin; oral

1.3

7.9

638

5082

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

7.9

716

5801

R06AX27

ATC

desloratadine; oral

1.3

7.8

767

6275

SBB10

NOMESCO Finland

Teeth copy

1.6

7.8

197

1258

L01

ICPC

Neck symptom/complaint

1.4

7.8

355

2582

N05CF01

ATC

zopiclone; oral

1.3

7.7

885

7377

N03AX12

ATC

gabapentin; oral

1.4

7.7

399

2967

R03BB04

ATC

tiotropium bromide; inhalant

1.5

7.7

255

1739

H05

ICPC

Bleeding ear

5.6

7.7

J01FA01

ATC

erythromycin; systemic

1.4

7.6

389

2884

SPAT1283

SPAT

Restricted health certificate

1.3

7.6

500

3865

H83.0

ICD-10 Finland

Labyrinthitis

11.9

7.6

DPA30

NOMESCO Finland

Sphenotomy

4.5

7.5

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

7.5

131

752

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

2.5

7.5

216

S02CA03

ATC

hydrocortisone and antiinfectives; otic

10.0

7.5

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.7

7.5

133

772

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

7.5

361

2652

DFF59

NOMESCO Finland

Other assessment of balance

3.6

7.4

J01MA01

ATC

ofloxacin; systemic

1.5

7.4

224

1496

R13

ICD-10 Finland

Dysphagia

1.6

7.4

171

1066

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

7.4

218

1448

7490B

ICD-9 Finland

Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS INCOMPLETA]

80.2

7.4

DBD10

NOMESCO Finland

Reconstruction of external auditory canal

80.2

7.4

DDA10

NOMESCO Finland

Exploration of ossicular chain

80.2

7.4

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

2.5

7.4

212

A04

ICPC

Weakness/tiredness general

1.4

7.4

360

2648

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

7.3

379

2816

DDD10

NOMESCO Finland

Interposition between malleus and stapes

+∞

7.3

E0000UV

ATC

1.2

7.3

1160

10034

4224

FHL

Endonasal anthrostomy

3.0

7.2

126

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

7.2

106

577

H92.2

ICD-10 Finland

Otorrhagia

6.2

7.2

UKC02

NOMESCO Finland

Cystoscopy

1.4

7.2

410

3096

ZFX00

NOMESCO Finland

Use of balloon dilatation

15.8

7.2

S29

ICPC

Skin symptom/complaint other

1.3

7.2

460

3540

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

7.2

119

677

C03CA01

ATC

furosemide; systemic

1.3

7.2

737

6060

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

7.2

231

1565

R52.9

ICD-10 Finland

Pain, unspecified

1.5

7.2

221

1486

Q90.9

ICD-10 Finland

Down syndrome, unspecified

30.1

7.1

Q35.71

ICD-10 Finland

Submucous cleft palate

30.1

7.1

ZXD05

NOMESCO Finland

Urgent procedure

1.2

7.1

896

7548

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

7.1

269

1890

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

7.1

620

4992

L12

ICPC

Hand/finger symptom/complaint

1.4

7.1

387

2904

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

7.1

428

3263

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

4.5

7.1

SPAT1262

SPAT

Handing over of treatment supplies

1.3

7.1

487

3791

H91.1

ICD-10 Finland

Presbycusis

1.7

7.1

148

904

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

3.6

7.0

R05

ICPC

Cough

1.3

7.0

619

4988

B01AB05

ATC

enoxaparin; parenteral

1.3

7.0

824

6880

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

7.0

438

3359

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

7.0

925

7834

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

7.0

299

2148

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

6.9

205

1364

Z01.2

ICD-10 Finland

Dental examination

1.2

6.9

1209

10542

SPAT1360

SPAT

Extensive global examination

1.5

6.9

200

1321

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.0

6.9

394

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

3.2

6.9

108

J46

ICD-10 Finland

Status asthmaticus

2.1

6.9

371

M54.5

ICD-10 Finland

Low back pain

1.2

6.9

921

7806

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.9

6.8

508

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

6.8

1208

10539

4452

FHL

Tonsil surgery

2.0

6.8

424

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

6.8

101

554

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.7

6.8

121

703

J47

ICD-10 Finland

Bronchiectasis

2.4

6.8

235

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

1.8

6.8

110

621

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

6.8

645

5249

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.1

6.7

335

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

6.7

635

5164

Q35.9

ICD-10 Finland

Cleft palate, unspecified

22.5

6.7

H62.2

ICD-10 Finland

Otitis externa in mycoses

22.5

6.7

R09

ICPC

Sinus symptom/complaint

1.5

6.7

203

1358

N07BA03

ATC

varenicline; oral

1.7

6.6

127

756

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

6.6

1111

9638

E000001

ATC

1.3

6.6

571

4586

H81.3

ICD-10 Finland

Other peripheral vertigo

2.0

6.6

388

SPAT1325

SPAT

Vaccination

1.2

6.6

1015

8727

R05FB02

ATC

cough suppressants and expectorants

1.2

6.5

1027

8853

R03AC12

ATC

salmeterol; inhalant

1.7

6.5

115

669

S01

ICPC

Pain/tenderness of skin

1.8

6.5

109

621

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

6.5

309

2267

D11

ICPC

Diarrhoea

1.4

6.5

302

2204

A10AE04

ATC

insulin glargine; parenteral

1.5

6.5

237

1654

S02

ICPC

Pruritus

1.8

6.4

544

ENC80

NOMESCO Finland

Plastic operation of soft palate for voice distubance

70.0

6.4

ECB17

NOMESCO Finland

Operation for cleft gingiva

70.0

6.4

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

6.4

245

1722

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

6.4

103

581

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.0

6.4

365

7492A

ICD-9 Finland

Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS UNILATERALIS COMPLETA]

14.3

6.4

4364

FHL

Pharyngeal tongue plastic

14.3

6.4

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

6.4

1010

8702

N30.0

ICD-10 Finland

Acute cystitis

1.4

6.4

361

2728

N07BB01

ATC

disulfiram; oral

1.8

6.4

110

635

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

3.0

6.3

110

H03AA01

ATC

levothyroxine sodium; systemic

1.3

6.3

607

4942

DFF40

NOMESCO Finland

Otoneurologic examination of vertigo

5.2

6.3

SPAT1216

SPAT

Assessment of functional ability

1.3

6.3

402

3093

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.2

6.3

290

XG410

NOMESCO Finland

Flow-volume spirometry

1.7

6.3

111

646

H83.1

ICD-10 Finland

Labyrinthine fistula

18.0

6.3

B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

3.0

6.3

111

DBA00

NOMESCO Finland

Incision of external auditory canal

+∞

6.2

4146

FHL

Radical cutting (bridge broken)

+∞

6.2

DGW99

NOMESCO Finland

Other operation on eustachian tube

+∞

6.2

3890A

ICD-9 Finland

Deafness, Conductive deafness

26.7

6.2

Q90.0

ICD-10 Finland

Trisomy 21, meiotic nondisjunction

26.7

6.2

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.1

6.2

293

B01AC04

ATC

clopidogrel; oral

1.3

6.2

393

3018

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

6.2

343

2579

K03.66

ICD-10 Finland

Tooth plaque

1.6

6.2

166

1081

N01

ICPC

Headache

1.4

6.2

291

2130

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

6.2

517

4135

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.0

6.2

383

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

1.6

6.2

137

850

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.3

6.2

625

5120

602

Kela drug reimbursment

Children's severe malnutrition

5.7

6.1

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

1139

3827

3.73

282.14

2.4

1.7

—

(3000494) Fungus identified in Specimen by Culture

756

3796

2.21

76.28

1.7

1.4

—

(3042936) Bacteria identified in Isolate by Culture

834

4576

2.03

65.72

2.2

2.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2825

24473

1.49

29.61

4.8

4.0

mm/h

12.9

11.8

3.37

2586

22648

(3037467) Urinalysis macro (dipstick) panel - Urine

2672

22975

1.46

28.43

5.0

4.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2290

19270

1.42

26.37

5.5

4.6

mmol/l

6.8

6.7

0.80

2134

17941

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1814

14648

1.43

26.31

7.0

5.9

mmol/l

1.2

0.24

1620

13273

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1968

16151

1.42

25.92

8.1

6.6

mmol/l

1.2

0.64

1689

13634

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1641

13094

1.42

25.05

2.1

2.0

pmol/l

95.0

95.4

0.10

857

6815

(42870588) Differential panel, method unspecified - Blood

1448

11322

1.43

24.65

6.9

5.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3632

33637

1.67

24.63

17.6

13.7

mg/l

23.4

23.5

0.06

2960

26447

(3031040) Bacteria [#/volume] in Urine by Automated count

2544

21945

1.42

24.61

4.9

4.4

e6/l

1304.0

1781.0

0.20

299

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2858

25204

1.44

24.20

8.4

7.4

u/l

79.8

78.5

0.74

2684

23774

(3013115) Eosinophils [#/volume] in Blood

2076

17358

1.40

23.68

7.0

6.0

e9/l

0.2

3.32

1818

15236

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2026

16888

1.39

23.44

6.5

6.1

umol/l

12.0

11.5

0.49

1911

15986

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1316

10211

1.42

22.99

2.7

2.6

u/l

55.7

57.6

0.83

1220

9422

(3019550) Sodium [Moles/volume] in Serum or Plasma

3644

33922

1.64

22.43

19.7

15.6

mmol/l

139.6

0.84

3544

33029

(3023103) Potassium [Moles/volume] in Serum or Plasma

3650

34010

1.64

22.15

19.9

15.8

mmol/l

4.0

0.33

3546

33057

(3019198) Lymphocytes [#/volume] in Blood

2053

17252

1.38

22.08

6.8

5.8

e9/l

1.9

0.45

1816

15178

(3018010) Neutrophils/100 leukocytes in Blood

1928

16040

1.38

22.04

6.7

5.9

56.9

0.00

1792

15044

(3019309) Folate [Moles/volume] in Red Blood Cells

829

5943

1.49

21.76

1.8

1.7

nmol/l

1102.7

1168.5

1.14

611

4468

(3006315) Basophils [#/volume] in Blood

2001

16794

1.37

21.44

6.8

5.8

e9/l

0.0

1.76

1743

14497

(3002030) Lymphocytes/100 leukocytes in Blood

1947

16292

1.37

21.14

7.1

6.0

28.1

28.3

0.20

1810

15233

(3001604) Monocytes [#/volume] in Blood

1992

16733

1.37

21.09

6.7

5.8

e9/l

0.6

2.18

1736

14445

(3019069) Monocytes/100 leukocytes in Blood

1894

15815

1.37

20.67

7.4

6.3

8.6

0.15

1765

14855

(3024561) Albumin [Mass/volume] in Serum or Plasma

1704

14029

1.37

20.17

5.6

4.8

g/l

35.5

35.6

0.52

1588

13040

(3006504) Eosinophils/100 leukocytes in Blood

1880

15723

1.36

20.10

7.0

6.0

3.0

2.8

1.43

1744

14689

(3022096) Basophils/100 leukocytes in Blood

1826

15252

1.35

19.46

7.1

6.0

0.7

0.59

1691

14275

(3023368) Bacteria identified in Blood by Culture

1129

8748

1.40

19.15

4.8

4.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2246

19407

1.35

18.90

9.7

8.9

e9/l

4.3

4.1

2.03

1976

16903

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3318

30582

1.44

18.14

5.1

4.7

mu/l

2.0

0.19

3011

28121

(3019225) pH of Specimen

480

3194

1.57

17.52

4.1

4.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

719

5272

1.44

16.30

2.1

1.8

—

(3026008) Bacteria identified in Urine by Culture

1222

9809

1.35

16.08

3.4

3.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2491

22143

1.32

15.75

3.4

3.1

u/l

49.9

46.9

0.88

2326

20691

(3032080) INR in Blood by Coagulation assay

1549

12904

1.32

15.71

9.6

9.1

inr

1.3

0.10

429

3774

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1624

13626

1.32

15.62

2.6

2.2

nmol/l

75.0

76.4

1.21

1445

12289

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

237

1357

1.79

15.35

2.1

1.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3735

35507

1.56

14.94

12.0

10.0

u/l

27.6

26.2

2.16

3588

34265

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

548

3875

1.48

14.93

4.5

4.4

32.5

32.4

0.02

351

2615

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1193

9661

1.33

14.48

2.3

2.1

u/l

177.2

228.3

1.52

1109

9079

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1446

12050

1.31

14.25

4.0

3.6

ng/l

119.5

87.4

0.18

984

8056

(3005322) IgE [Units/volume] in Serum or Plasma

325

2074

1.62

14.09

1.5

1.3

u/ml

304.1

209.7

0.62

301

1906

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2823

25719

1.31

13.89

4.2

4.0

pmol/l

14.8

14.7

0.71

2531

23383

(3047181) Lactate [Moles/volume] in Blood

184

1007

1.87

13.81

5.8

6.5

mmol/l

1.4

1.3

0.58

164

883

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

215

1237

1.78

13.71

2.0

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

377

2508

1.55

13.68

3.4

2.6

g/l

10.3

10.5

0.21

347

2274

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1307

10820

1.30

13.30

3.6

3.2

u/l

33.1

35.7

0.51

1234

10260

(3020682) Albumin/Creatinine [Ratio] in Urine

1175

9631

1.31

12.76

4.1

4.0

mg/mmol

10.3

9.0

0.37

748

6134

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1807

15651

1.28

12.76

4.7

4.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

227

1357

1.71

12.67

2.7

1.4

u/ml

18.9

15.9

0.12

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3372

31645

1.36

12.65

4.7

4.4

mmol/l

5.9

1.43

3062

28908

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3190

29695

1.33

12.61

6.1

5.5

mmol/mol

39.9

39.5

1.62

2911

27520

(3035941) MCH [Entitic mass]

3895

37574

1.67

12.54

25.1

19.9

30.2

0.10

3828

37024

(3024731) MCV [Entitic volume]

3895

37575

1.67

12.53

25.2

19.9

90.8

90.7

0.63

3829

37029

(3010813) Leukocytes [#/volume] in Blood

3896

37588

1.67

12.52

25.3

20.0

e9/l

7.0

6.7

3.96

3793

36483

(3026361) Erythrocytes [#/volume] in Blood

3895

37580

1.67

12.46

25.3

20.0

e12/l

4.5

3.39

3785

36494

(3007461) Platelets [#/volume] in Blood

3892

37547

1.66

12.41

25.3

20.0

e9/l

252.1

251.7

0.12

3797

36557

(3000963) Hemoglobin [Mass/volume] in Blood

3895

37593

1.66

12.27

25.4

20.1

g/l

134.5

135.4

3.46

3833

37053

(3013512) EKG study

1114

9108

1.31

12.23

4.4

3.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1048

8522

1.31

11.92

2.4

2.2

mg/l

2.9

0.09

889

7264

(3022313) Gas panel - Capillary blood

241

1495

1.65

11.71

5.2

4.0

—

(3044640) Blood type and Crossmatch panel - Blood

1258

10506

1.28

11.62

2.7

2.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1078

8833

1.30

11.52

3.2

3.0

ng/l

1458.1

1420.2

0.10

924

7548

(3003458) Phosphate [Moles/volume] in Serum or Plasma

570

4265

1.39

11.22

6.8

6.0

mmol/l

1.1

0.42

524

3969

(3039000) Anion gap in Blood

134

709

1.92

11.21

6.4

7.7

mmol/l

11.2

11.3

0.12

119

635

(3018572) Chloride [Moles/volume] in Blood

134

710

1.92

11.17

6.4

7.7

mmol/l

104.8

105.3

0.48

119

636

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

312

2086

1.54

11.06

5.4

3.7

kpa

5.1

5.2

0.12

290

1930

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

183

1076

1.73

10.88

2.0

1.5

titre

207.3

277.5

0.27

(3009343) pH of Capillary blood

307

2062

1.53

10.65

5.4

3.7

7.4

0.40

246

(40761511) CBC panel - Blood by Automated count

3658

34981

1.41

10.61

16.6

12.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1295

10962

1.26

10.47

3.4

3.3

mmol/l

2.3

2.4

1.62

1091

9616

(3021960) Folate [Moles/volume] in Serum or Plasma

924

7503

1.30

10.42

1.7

1.5

nmol/l

20.1

20.4

0.25

782

6444

(3009508) Creatinine [Moles/volume] in Urine

1203

10101

1.27

10.40

3.6

3.3

mmol/l

7.6

0.17

1005

8523

(3037522) Nuclear Ab [Titer] in Serum

584

4442

1.37

10.35

1.3

titre

653.5

552.0

0.50

130

909

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

297

1995

1.53

10.30

5.3

3.7

mmol/l

1.6

1.7

0.18

218

1465

(3007930) Methemoglobin/Hemoglobin.total in Blood

207

1280

1.65

10.22

5.5

0.9

0.91

192

1202

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

175

1035

1.72

10.20

3.7

2.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3464

32897

1.33

10.04

4.9

4.7

mmol/l

2.7

2.8

1.90

3156

30366

(4010399)

324

2229

1.49

10.03

1.5

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

261

1715

1.56

10.01

10.7

9.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

335

2337

1.47

9.68

1.8

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

205

1288

1.62

9.51

5.4

1.7

0.17

190

1205

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

209

1320

1.61

9.50

5.6

4.1

mmol/l

24.8

0.04

198

1224

(3008152) Bicarbonate [Moles/volume] in Arterial blood

291

1985

1.50

9.40

6.1

6.9

mmol/l

24.4

24.5

0.17

267

1849

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3405

32327

1.31

9.38

4.4

4.2

mmol/l

4.6

4.14

3123

30021

(3012516) Albumin [Mass/volume] in Urine

1090

9144

1.26

9.30

3.4

3.3

mg/l

426.1

336.4

0.26

714

5833

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

371

2679

1.42

8.92

3.1

2.9

ng/l

173.5

199.1

0.65

335

2421

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3377

32076

1.29

8.91

4.4

4.2

mmol/l

1.4

1.5

6.65

3082

29643

(3015171) Extractable nuclear Ab [Units/volume] in Serum

195

1233

1.61

8.84

1.3

1.2

u/ml

1.4

1.1

0.18

103

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

490

3714

1.36

8.82

2.8

umol/l

10.1

8.1

0.52

410

3210

(3023520) Reticulocytes [#/volume] in Blood

371

2686

1.42

8.79

2.9

2.6

e9/l

69.9

69.7

0.03

284

2011

(3019060) Gas panel - Arterial blood

298

2075

1.47

8.70

4.8

4.9

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

111

604

1.86

8.61

1.7

1.2

titre

181.8

331.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

642

5085

1.31

8.56

2.8

2.4

umol/l

12.6

13.3

1.49

602

4714

(3026493) Urate [Moles/volume] in Serum or Plasma

996

8355

1.25

8.36

2.7

2.6

umol/l

3631.6

4878.1

0.50

868

7247

(3003396) Base excess in Arterial blood by calculation

478

3640

1.35

8.34

8.5

7.1

mmol/l

1.0

1.1

0.10

360

2837

(3028026) IgM [Mass/volume] in Serum or Plasma

284

1976

1.47

8.33

1.9

1.8

g/l

1.3

1.4

0.28

263

1800

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

765

6225

1.28

8.28

4.1

3.7

ng/l

331.6

566.3

0.69

586

4749

(3019150) Specific gravity of Urine by Refractometry

868

7176

1.27

8.25

4.2

4.0

kg/l

1.0

0.08

144

1072

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1678

14890

1.21

8.21

3.2

2.8

ug/l

129.9

120.8

0.52

1542

13823

(3020779) Urea [Moles/volume] in Serum or Plasma

390

2887

1.39

8.12

9.1

7.5

mmol/l

10.2

9.6

0.76

369

2758

(3015736) pH of Urine

1447

12685

1.22

7.94

3.7

3.4

—

5.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

142

852

1.69

7.93

1.5

1.4

iu/ml

45.4

12.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

833

6882

1.26

7.92

1.7

pmol/l

74964657.6

27071102.6

1.06

699

5759

(3018677) aPTT in Platelet poor plasma by Coagulation assay

624

4975

1.30

7.88

2.1

2.2

29.5

29.8

0.45

603

4822

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3259

30941

1.26

7.85

4.0

3.8

mmol/l

1.3

2.46

2956

28413

(3018418) pH of Serum or Plasma

1117

9547

1.23

7.83

4.2

4.0

7.4

0.24

165

1824

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

4.18

7.72

1.2

ng/l

57.5

80.0

0.20

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

953

8028

1.24

7.61

2.6

2.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

473

3647

1.34

7.59

8.5

7.1

kpa

5.1

0.36

444

3481

(3027801) Oxygen [Partial pressure] in Arterial blood

473

3647

1.34

7.59

8.5

7.1

kpa

12.0

12.4

0.84

442

3478

(3016502) Oxygen saturation in Arterial blood

428

3252

1.35

7.57

9.0

7.5

95.7

95.6

0.21

404

3130

(3011412) CD3 cells [#/volume] in Blood

314

2.12

7.54

2.3

2.5

e9/l

1.2

1.1

0.53

182

(3035350) Ketones [Presence] in Urine by Test strip

1809

16260

1.20

7.51

4.0

3.6

estimate

0.0

1.08

287

3034

(3012544) pH of Venous blood

422

3205

1.35

7.49

4.8

3.8

—

7.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

470

3628

1.33

7.48

1.9

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

1808

16258

1.20

7.45

5.5

4.9

estimate

0.0

0.50

299

3105

(3009261) Glucose [Presence] in Urine by Test strip

1826

16439

1.20

7.42

4.0

3.6

estimate

0.0

1.32

291

3014

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

470

3636

1.33

7.37

2.0

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

233

2.29

7.34

2.4

2.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

397

2999

1.36

7.29

9.5

7.9

g/l

121.6

122.0

0.17

377

2891

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

505

3961

1.31

7.18

6.7

6.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

191

1264

1.54

7.17

2.0

ug/l

1.2

2.1

0.99

168

1115

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

332

2446

1.39

7.12

4.4

3.9

ng/l

90.7

87.3

0.29

289

2112

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

795

6611

1.25

7.07

1.7

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

512

1.84

7.03

3.7

3.5

0.8

1.6

3.37

394

(3027273) Bicarbonate [Moles/volume] in Venous blood

222

1523

1.48

7.03

5.0

3.3

mmol/l

25.4

25.2

0.23

216

1473

(3028433) Virus identified in Specimen by Culture

113

2.85

6.94

1.3

1.2

—

(3002032) Base excess in Venous blood by calculation

406

3103

1.34

6.91

5.1

3.9

mmol/l

1.8

1.9

0.30

334

2513

(3004789) Transferrin [Mass/volume] in Serum or Plasma

582

4675

1.29

6.90

2.9

2.4

g/l

2.4

2.3

1.24

540

4329

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

856

7199

1.24

6.86

1.8

mg/l

1.1

1.2

0.93

638

5417

(3008757) Leukocyte morphology finding [Identifier] in Blood

347

2.01

6.83

3.9

3.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

121

726

1.69

6.81

1.4

—

(3037121) Protein [Mass/volume] in Urine

176

1158

1.54

6.80

3.1

3.3

g/l

0.4

0.3

0.32

489

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

147

928

1.61

6.79

1.7

1.6

g/l

0.2

0.12

139

877

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

242

2.21

6.74

2.3

2.1

11.6

13.4

0.70

112

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

546

4366

1.29

6.70

3.0

2.5

20.7

23.0

4.30

442

3735

(3017354) Segmented neutrophils/100 leukocytes in Blood

316

2.04

6.67

3.4

3.6

64.0

57.1

1.76

202

(3021447) Carbon dioxide [Partial pressure] in Venous blood

405

3115

1.33

6.60

5.2

3.8

kpa

5.9

5.8

0.67

390

3024

(3022217) INR in Platelet poor plasma by Coagulation assay

516

4105

1.29

6.59

24.0

25.2

inr

1.3

0.01

577

(3026389) Candida sp identified in Specimen by Organism specific culture

460

1.84

6.49

1.6

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

636

5207

1.26

6.44

3.8

3.5

mmol/l

0.8

0.23

595

4858

(3027945) Reticulocytes/100 erythrocytes in Blood

465

3663

1.30

6.39

2.9

2.6

1.9

1.8

1.02

393

3230

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

467

3688

1.30

6.30

4.3

4.2

u/l

234.3

245.1

1.03

439

3483

(3017732) Neutrophils [#/volume] in Blood

299

2217

1.38

6.19

3.1

3.0

e9/l

3.9

4.1

0.69

209

1756

(3024139) IgG subclass 3 [Mass/volume] in Serum

305

2.02

6.18

1.3

1.4

g/l

0.4

0.22

214

(3028192) IgG subclass 2 [Mass/volume] in Serum

305

2.02

6.18

1.3

1.4

g/l

3.0

0.02

215

(3027135) IgG subclass 1 [Mass/volume] in Serum

305

2.02

6.18

1.3

1.4

g/l

6.6

6.9

0.22

214

(4062490)

307

2.00

6.07

1.4

—

(3014271) Vancomycin [Susceptibility]

152

2.45

6.01

3.1

2.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

668

5541

1.25

6.01

1.3

iu/ml

36.6

32.2

0.26

203

1707

(3002179) Metamyelocytes/100 leukocytes in Blood

331

2510

1.35

5.95

4.1

3.9

0.5

0.6

0.62

552

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

147

959

1.55

5.94

1.7

1.6

g/l

1.2

0.38

139

907

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

979

8461

1.21

5.89

1.7

1.6

mmol/l

1.4

0.29

840

7156

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

167

2.35

5.81

1.4

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

167

2.35

5.81

1.4

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

167

2.35

5.81

1.4

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

167

2.35

5.81

1.4

1.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

299

1.99

5.78

1.2

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2410

22507

1.17

5.67

3.3

3.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

274

2.02

5.66

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

274

2.02

5.66

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

274

2.02

5.66

1.5

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3224

30879

1.20

5.51

15.3

12.7

ml/min/173m2

82.9

82.8

0.10

2627

25269

(3017181) Myelocytes/100 leukocytes in Blood

356

2760

1.32

5.51

4.2

4.1

0.8

0.18

118

758

(3002582) Erythrocytes [#/volume] in Urine

1131

9962

1.19

5.45

3.6

3.2

e6/l

47.1

83.4

1.50

875

7600

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

123

789

1.58

5.39

1.7

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

2.79

5.29

2.2

2.3

e6/l

135.9

164.8

0.26

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

137

2.42

5.28

1.0

1.1

u/ml

9.0

7.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

108

675

1.62

5.28

1.2

u/ml

14.7

3.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

137

906

1.53

5.25

1.2

1.3

u/ml

14.3

39.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

390

1.81

5.19

1.3

1.4

pmol/l

300.6

284.4

0.16

301

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

346

2699

1.31

5.13

2.3

2.4

ug/l

5.8

7.1

0.96

284

2367

(40768797) Stomach Pathology biopsy report

538

4435

1.25

5.10

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1111

9828

1.18

5.03

5.1

4.9

ug/l

2.8

3.3

0.39

972

8816

(3015235) Bicarbonate [Moles/volume] in Capillary blood

123

803

1.55

5.02

4.2

3.1

mmol/l

23.7

24.9

2.08

109

697

(3004119) Hemoglobin [Mass/volume] in Venous blood

261

1962

1.35

5.00

4.9

3.3

g/l

128.6

129.4

0.21

254

1912

(3044927) Protein electrophoresis panel - Urine

316

1.88

4.97

1.3

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

624

5241

1.22

4.96

1.3

1.2

u/ml

17.5

11.8

0.85

222

2027

(3025941) Bacteria identified in Stool by Culture

256

1923

1.35

4.94

1.3

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

404

1.77

4.93

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

335

2622

1.30

4.86

4.3

4.1

0.2

0.1

0.56

109

700

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

513

1.67

4.80

2.9

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

881

7670

1.19

4.78

3.8

3.6

—

(3018095) Leukocytes [#/volume] in Urine

1304

11727

1.16

4.75

4.2

3.6

e6/l

76.6

95.3

0.66

941

8190

(4015189)

2.79

4.71

1.9

2.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

208

1524

1.38

4.70

3.8

2.8

1.3

1.2

1.10

208

1510

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.65

4.64

1.5

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

330

2594

1.30

4.64

4.6

3.3

kpa

4.8

4.6

0.78

317

2511

(3009542) Hematocrit [Volume Fraction] of Blood

3240

31178

1.18

4.63

18.5

14.5

39.4

39.9

1.83

2196

22817

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

125

835

1.51

4.62

1.3

u/ml

15.0

3.5

0.63

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.22

4.61

1.5

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.22

4.61

1.5

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.22

4.61

1.5

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.06

4.51

1.2

1.1

—

(3025159) Blasts/100 leukocytes in Blood

314

2466

1.30

4.46

4.3

4.1

0.0

0.4

1.00

590

(3023419) Bacteria identified in Sputum by Culture

410

1.72

4.44

4.6

2.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

410

1.72

4.44

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

156

1101

1.43

4.39

2.4

2.3

ug/l

1497.1

473.9

0.37

145

1031

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

125

847

1.49

4.34

1.3

u/ml

14.8

9.1

0.30

146

(3024980) IgG subclass 4 [Mass/volume] in Serum

498

1.64

4.30

1.7

g/l

1.1

0.8

0.49

388

(3023183) Ammonium ion [Moles/volume] in Plasma

104

679

1.55

4.30

2.1

2.8

umol/l

38.1

35.5

0.26

579

(3036481) Cortisol [Moles/volume] in Serum or Plasma

382

3095

1.26

4.23

2.4

2.1

nmol/l

370.8

0.00

351

2831

(3000034) Microalbumin [Mass/volume] in Urine

284

1.84

4.18

2.6

3.0

mg/l

43.4

42.5

0.01

213

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

200

1486

1.36

4.18

3.6

2.7

0.7

0.05

192

1423

(3014576) Chloride [Moles/volume] in Serum or Plasma

486

4050

1.23

4.17

9.0

6.6

mmol/l

104.8

104.4

0.99

474

3958

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

403

1.70

4.16

1.5

—

(40758558) Short blood count panel - Blood

951

8421

1.17

4.15

7.6

6.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

566

1.59

4.13

1.7

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

327

2608

1.28

4.13

3.0

2.5

g/l

65.7

66.5

1.08

293

2393

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

498

1.62

4.06

1.7

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

127

876

1.46

4.06

1.4

mg/l

532.6

509.6

0.14

120

824

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

209

1.97

4.05

1.2

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

377

3071

1.25

3.99

2.1

2.3

g/l

0.2

0.07

347

2861

(1761868) Lipid panel - Serum or Plasma

1045

11614

0.87

3.90

2.8

2.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

113

769

1.48

3.88

1.4

1.5

e6/l

28.9

14.6

0.32

593

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

113

769

1.48

3.88

1.5

e6/l

776.5

1240.8

0.27

627

(4146454)

322

1.75

3.84

2.8

2.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

264

1.83

3.81

2.1

2.3

37.8

42.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

429

1.64

3.80

1.7

1.4

—

(3011985) Renin [Units/volume] in Plasma

414

1.65

3.79

1.6

1.5

mu/l

72.4

53.0

0.41

365

(3026782) Osmolality of Urine

738

6448

1.18

3.78

3.2

2.7

mosm/kgh2o

553.9

548.7

0.23

621

5475

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.76

3.77

6.0

7.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

246

1916

1.30

3.76

1.7

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

400

1.66

3.75

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

393

1.66

3.73

2.5

2.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

107

727

1.48

3.72

3.2

3.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

875

7764

1.16

3.68

1.3

u/ml

1.4

1.6

0.27

219

2035

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

246

1922

1.30

3.68

1.8

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

664

1.50

3.67

1.2

u/ml

56.9

37.9

0.51

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

113

779

1.46

3.66

1.8

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

403

1.65

3.65

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

490

4143

1.21

3.64

2.0

1.8

1.5

1.4

0.61

434

3657

(3000850) Epithelial cells [#/volume] in Urine

782

6886

1.17

3.63

2.9

2.6

e6/l

6.9

5.8

0.83

681

6027

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

642

1.51

3.61

6.4

6.2

iu/ml

279.2

2914.5

0.58

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

131

932

1.42

3.59

1.6

1.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

112

774

1.46

3.59

1.4

mmol/l

3.5

3.7

1.93

103

720

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

226

1.87

3.58

1.4

1.2

—

(3037756) Immunofixation for Serum or Plasma

644

1.50

3.56

1.7

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

406

1.64

3.56

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

269

2137

1.28

3.54

2.2

2.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

770

6788

1.17

3.52

1.6

1.4

g/l

2.4

0.21

487

4139

(3027923) C peptide [Moles/volume] in Serum or Plasma

179

1.96

3.47

1.8

1.4

nmol/l

1.4

1.2

0.24

140

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

112

2.24

3.47

3.2

2.1

u/ml

160.0

29588.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

265

1.78

3.47

1.9

1.4

promille

1.2

1.3

0.18

205

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

229

1.84

3.45

1.4

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

402

1.63

3.44

1.5

—

(3041354) Potassium [Moles/volume] in Venous blood

402

1.63

3.44

2.5

2.4

mmol/l

4.1

0.10

394

(3035285) Chloride [Moles/volume] in Venous blood

402

1.63

3.44

2.5

2.4

mmol/l

104.9

105.5

0.35

394

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

193

1473

1.33

3.44

1.9

1.8

g/l

1.4

1.5

0.57

164

1276

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1368

12572

1.13

3.41

4.3

3.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

450

1.59

3.41

1.8

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.99

3.41

1.7

1.5

—

(3002619) Bacteria identified in Specimen by Culture

2.66

3.39

1.2

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.01

3.37

1.6

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

186

1418

1.33

3.35

5.9

3.8

50.1

49.0

0.25

186

1398

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

144

1056

1.38

3.34

1.7

1.6

iu/ml

0.3

6.1

0.56

226

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

662

1.48

3.33

1.6

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

352

1.66

3.32

2.6

1.9

ug/l

27.5

26.6

0.03

346

(3000570) Elastase.pancreatic [Mass/mass] in Stool

129

930

1.40

3.31

1.3

1.4

ug/g

253.8

287.2

1.08

519

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.42

3.30

1.1

1.2

—

(3042631) Mycobacterium sp identified in Specimen

415

1.60

3.29

3.1

2.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

233

1.81

3.29

2.2

2.7

e6/l

646.8

718.2

0.34

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

137

1001

1.38

3.25

2.5

2.9

g/l

3.7

3.5

0.56

126

951

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

136

2.07

3.21

1.6

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

136

2.07

3.21

1.6

2.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

104

728

1.44

3.16

2.8

2.1

g/l

126.5

130.1

0.75

534

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

413

1.58

3.12

1.3

—

(3045424) Erythrocytes [Presence] in Urine

541

1.51

3.11

1.3

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

603

5265

1.17

3.11

3.1

2.9

e6/l

2.6

2.4

0.19

345

2826

(3048689) Calprotectin [Mass/mass] in Stool

494

4243

1.19

3.10

2.5

2.4

ug/g

159.6

130.9

0.69

387

3354

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

138

2.04

3.10

1.6

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

484

4152

1.19

3.09

1.7

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

212

1666

1.29

3.08

2.5

2.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

107

757

1.42

3.08

1.6

e6/l

12009.7

13724.3

0.17

547

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

503

1.52

3.06

4.4

3.2

u/ml

914.0

1739.3

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

217

1.80

3.05

2.8

3.1

nmol/l

164.4

128.3

0.23

212

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

187

1451

1.30

3.00

2.3

u/l

6401.0

6038.8

0.03

554

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

3.01

2.97

1.0

u/ml

1.1

0.2

—

(4027681)

219

1.79

2.96

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

452

1.54

2.92

1.3

nmol/l

0.6

0.63

433

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

398

1.57

2.87

2.1

2.2

mg/l

22.8

22.4

0.02

(40768804) Tissue Pathology biopsy report

1422

13215

1.12

2.82

2.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

128

950

1.36

2.81

1.1

u/ml

18.6

4.0

—

120

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

457

1.52

2.79

1.3

nmol/l

0.1

0.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

126

935

1.36

2.77

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

100

714

1.41

2.77

1.4

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

130

971

1.35

2.74

3.1

3.4

mg/l

49.6

68.4

0.45

112

788

(3010503) CD19 cells [#/volume] in Blood

196

1.79

2.71

2.2

2.6

e9/l

0.2

0.01

188

(3020891) Body temperature

164

1270

1.30

2.70

5.2

4.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.01

2.70

6.2

5.0

—

(3038515) Glucose [Moles/volume] in Venous blood

659

1.42

2.69

4.3

3.2

mmol/l

8.2

7.5

1.28

639

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

626

1.43

2.69

1.5

1.6

—

(3049717) Cytology report of Urine Cyto stain

151

1158

1.32

2.67

2.9

2.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.33

2.64

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

477

4145

1.17

2.63

2.1

—

(3000492) Spirometry study

373

3176

1.19

2.62

1.5

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

633

5622

1.15

2.61

2.9

2.7

e6/l

1.3

1.2

0.10

378

3173

(3034860) Kappa light chains.free [Mass/volume] in Serum

129

972

1.34

2.59

3.1

3.4

mg/l

78.6

117.4

0.25

111

787

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

379

3236

1.19

2.58

3.5

4.0

ug/l

29.8

20.7

0.30

305

2624

(3007566) Smooth muscle Ab [Titer] in Serum

122

913

1.35

2.57

1.2

1.3

titre

60.0

92.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

394

1.53

2.56

1.3

nmol/l

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

7.15

2.55

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

128

1.96

2.55

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

5.46

2.54

6.5

4.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

250

3022

0.82

2.52

1.7

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

145

1117

1.31

2.51

1.8

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

636

1.41

2.49

1.8

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

102

2.06

2.47

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

203

1.73

2.44

1.1

u/l

1.0

1.1

2.88

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

174

1.79

2.41

1.3

1.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

101

742

1.37

2.41

1.1

u/ml

0.7

1.7

1.37

315

(3030467) Casts [#/volume] in Urine by Automated count

996

9146

1.12

2.40

3.5

3.1

e6/l

0.4

0.55

743

6879

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.01

2.40

4.8

3.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

235

1.67

2.38

1.7

1.3

u/ml

0.9

1.2

0.11

(3008898) HLA-B27 [Presence]

150

1171

1.29

2.37

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

825

7501

1.12

2.36

5.2

4.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

630

5638

1.14

2.33

1.7

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

762

6902

1.13

2.32

2.0

1.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

260

1.62

2.32

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

119

904

1.33

2.30

5.9

4.6

mg/l

1.5

1.4

0.13

113

832

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

487

1.44

2.29

1.2

—

(3000991) Gas panel - Venous blood

328

2798

1.19

2.28

11.3

7.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

419

3648

1.17

2.28

1.7

—

(3021788) Differential panel - Synovial fluid

546

1.42

2.27

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

580

1.40

2.27

1.9

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

623

1.39

2.25

1.1

u/ml

0.9

2.7

2.23

154

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

286

1.58

2.24

1.2

1.1

mg/l

52.9

43.5

0.53

233

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

110

830

1.33

2.23

1.3

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

701

1.36

2.23

4.3

3.0

mmol/l

1.9

1.6

1.09

679

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

194

1.71

2.22

2.5

2.7

39.7

42.2

0.43

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.34

2.21

1.4

1.2

mmol/l

2.1

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

174

1400

1.25

2.18

1.8

1.9

u/l

39.2

39.3

0.01

147

1247

(40761535) Cells panel - Urine sediment

311

2654

1.19

2.17

3.8

3.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

101

1.98

2.15

2.0

3.2

—

(3016018) Differential panel - Cerebral spinal fluid

362

1.50

2.14

1.2

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

122

943

1.30

2.11

3.1

3.4

ratio

1.7

0.00

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.00

2.10

1.5

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

205

1688

1.23

2.09

4.8

4.1

mmol/l

23.7

24.1

0.80

182

1539

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

324

1.52

2.08

1.3

1.5

—

(3017704) Immunofixation for Urine

183

1.70

2.07

1.6

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

2.91

2.07

1.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

643

1.36

2.05

1.1

u/ml

1.2

1.3

0.01

285

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

366

1.48

2.05

1.6

1.5

55.8

58.9

0.22

235

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

230

1.61

2.04

1.5

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

474

1.42

2.04

1.0

1.1

u/ml

6.3

6.8

0.06

197

(3001019) Free T4 and TSH panel - Serum or Plasma

137

1723

0.79

2.03

1.7

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

855

7858

1.11

2.01

4.5

4.2

22.5

21.7

0.72

409

3761

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.50

2.01

1.0

u/ml

0.0

0.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.64

2.01

1.0

u/ml

0.2

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

185

1.68

2.00

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

140

1.79

2.00

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

140

1.79

2.00

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

295

1.53

2.00

1.6

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

344

1.49

1.99

2.0

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

109

839

1.31

1.97

7.4

3.5

kpa

8.6

8.4

0.61

101

780

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

461

1.42

1.96

1.4

u/l

18.3

24.2

0.94

387

(21494755) Public health laboratory ask at order entry panel

279

3253

0.85

1.95

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

2.19

1.94

2.6

2.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

963

8923

1.10

1.93

3.9

3.3

—

(3029937) Albumin [Presence] in Urine by Test strip

949

8788

1.10

1.93

4.6

4.0

estimate

0.0

1.28

293

2986

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

165

2016

0.81

1.91

1.3

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

330

2864

1.17

1.90

9.6

6.7

mmol/l

1.3

1.4

0.20

315

2755

(3037692) Legionella sp identified in Specimen by Organism specific culture

106

1.89

1.90

1.4

1.5

—

(3051651) Icteric interference index of Serum or Plasma

188

1.65

1.90

4.6

3.6

—

(3024928) Oxygen saturation in Venous blood

704

1.33

1.90

3.2

3.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

456

1.41

1.89

1.9

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

516

1.38

1.88

1.3

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.31

1.87

7.7

6.6

—

(3003129) Base excess in Capillary blood by calculation

2.09

1.86

1.1

1.9

mmol/l

-0.2

1.1

0.78

(36304419) Bacteria [Presence] in Urine

962

8931

1.10

1.85

3.4

3.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

120

944

1.28

1.85

2.6

2.7

194.8

187.6

0.35

114

907

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

182

1.65

1.84

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

673

1.33

1.84

1.1

u/ml

4.3

5.7

0.44

366

(3022145) Colonoscopy Study observation

404

3570

1.15

1.83

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

249

0.48

1.81

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

648

5901

1.12

1.81

3.0

mmol/l

2.4

0.43

576

5167

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

207

1.60

1.79

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

207

1.60

1.79

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

508

4566

1.13

1.78

2.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

264

1.52

1.76

1.2

1.3

mmol/l

2.0

0.01

247

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.09

1.75

2.2

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

124

1.78

1.75

2.0

2.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

149

1212

1.24

1.75

2.2

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

149

1212

1.24

1.75

2.2

2.3

g/l

7.1

7.4

2.10

104

912

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

149

1212

1.24

1.75

2.2

2.3

g/l

3.7

3.8

0.68

872

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

313

1.47

1.75

2.9

2.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

523

1.36

1.75

1.0

1.1

u/ml

3.5

4.6

0.26

197

(36660697) Celiac disease serology panel - Serum

320

2791

1.16

1.75

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.44

1.75

2.0

2.1

—

(3003338) MCHC [Mass/volume]

2969

28958

1.09

1.74

22.2

17.4

g/l

332.3

332.7

1.07

2943

28725

(3016650) Hepatitis A virus Ab [Presence] in Serum

558

1.35

1.74

1.1

—

(3017509) Phencyclidine [Presence] in Urine

2.50

1.74

1.6

1.5

—

(3023410) Appearance of Cerebral spinal fluid

355

1.44

1.73

1.6

1.8

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

132

1.75

1.73

1.3

1.8

umol/l

2.1

2.0

0.11

123

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

110

1.82

1.72

3.9

2.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

132

1062

1.25

1.72

3.5

u/ml

0.3

0.49

615

(3022621) pH of Urine by Test strip

251

2152

1.18

1.71

3.1

3.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

282

1.49

1.71

1.5

1.4

mmol/l

12.5

12.0

0.17

(3051611) Lipemic interference index of Serum or Plasma

315

1.47

1.70

4.3

3.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

218

1.56

1.70

1.2

1.3

u/l

12.8

11.6

0.27

200

(40768443) Skin Pathology biopsy report

168

1390

1.22

1.69

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.00

1.69

1.4

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

251

2155

1.18

1.69

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

240

2056

1.18

1.66

1.3

au/ml

53.5

48.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.10

1.65

3.2

2.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

260

2244

1.17

1.64

2.4

au/ml

17.0

23.9

0.87

126

(3006922) Hepatitis E virus Ab [Presence] in Serum

220

1.55

1.64

1.0

1.1

—

(3019977) pH of Arterial blood

181

1.61

1.63

3.0

2.5

7.4

—

(3035880) pH of Pleural fluid

166

1.63

1.61

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

336

1.43

1.61

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

378

1.41

1.60

2.0

1.7

—

(3048879) Bone marrow aspiration report

1.87

1.60

1.7

2.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

113

1.77

1.60

1.4

2.3

mg/l

8.7

9.8

0.39

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

320

1.44

1.59

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.91

1.59

1.0

1.2

g/l

45.8

38.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

681

1.30

1.58

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

681

1.30

1.58

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

114

1.76

1.56

2.6

2.5

—

(44806118)

372

1.40

1.55

1.6

1.5

—

(44790048)

372

1.40

1.55

1.6

1.5

—

(44790049)

372

1.40

1.55

1.6

1.5

—

(44790047)

372

1.40

1.55

1.6

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

710

1.29

1.55

1.6

1.3

u/ml

295.4

252.2

0.67

417

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.98

1.53

1.0

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.28

1.53

1.0

—

(3016228) CD19 cells/100 cells in Blood

130

1.70

1.52

2.0

2.1

10.3

9.2

0.11

124

(3035637) Corticotropin [Mass/volume] in Plasma

408

1.38

1.51

1.8

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

151

1256

1.21

1.48

1.5

1.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.37

1.45

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.37

1.45

1.3

1.8

umol/l

50.7

43.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

277

1.45

1.44

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

1133

1.22

1.43

2.0

2.4

g/l

2.9

3.1

1.66

892

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

1.73

1.42

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

118

1.70

1.41

1.6

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

149

1.61

1.40

3.5

4.3

—

(40768446) Kidney Pathology biopsy report

126

1.67

1.39

2.5

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

2.42

1.39

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

144

1201

1.21

1.39

1.5

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

749

1.26

1.38

1.6

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

196

1681

1.17

1.38

13.2

9.0

mmol/l

24.3

24.4

0.02

179

1578

(40762814) Titanium [Mass/volume] in Blood

2.08

1.38

1.8

2.2

ug/l

3.4

3.2

—

(44806420)

1.80

1.37

2.3

2.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

279

2461

1.14

1.36

2.2

2.1

nmol/l

11.8

12.6

0.77

239

2185

(3036489) Thrombin time

149

1250

1.20

1.36

2.2

2.3

21.8

21.5

0.29

133

1085

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

2.94

1.36

5.4

10.4

e6/l

271.8

207.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

223

1.48

1.35

1.6

1.5

u/ml

26.5

23.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

117

960

1.23

1.34

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

497

1.31

1.32

4.8

5.0

umol/l

386.7

366.4

0.46

433

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

701

1.26

1.31

1.8

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.74

1.30

2.2

2.0

—

(3045414) Leukocytes [Presence] in Urine

172

1468

1.18

1.30

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

209

1.49

1.30

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

121

1001

1.22

1.29

1.6

1.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.78

1.28

1.6

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

138

1.60

1.26

1.1

ng/l

95.7

454.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

127

1059

1.21

1.25

2.4

2.7

92.0

91.6

0.07

118

993

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

107

1.69

1.25

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

107

1.69

1.25

1.0

1.1

—

(3021901) Oxygen saturation in Capillary blood

581

1.28

1.25

3.6

2.8

—

(3044889) 12 lead EKG panel

2325

22606

1.07

1.25

3.8

3.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

135

1133

1.20

1.25

2.3

g/l

10.1

10.2

0.07

107

962

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

1.66

1.24

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

564

1.28

1.24

1.1

iu/ml

222.9

942.1

0.40

147

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

100

1.70

1.23

3.8

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

100

1.70

1.23

3.8

2.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

237

1.44

1.22

2.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.63

1.21

3.8

3.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

271

1.41

1.21

1.7

1.1

u/ml

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

116

1.64

1.21

2.3

1.9

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

280

1.40

1.20

1.4

1.3

nmol/l

1.7

1.5

0.59

254

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

101

1.69

1.19

1.1

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.83

1.19

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.11

1.18

1.6

3.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

212

1857

1.15

1.17

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

106

1277

0.83

1.17

1.8

1.7

mg/l

5.0

4.0

0.32

881

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

749

1.23

1.16

2.3

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.00

1.16

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

642

1.25

1.15

1.7

1.5

u/ml

109.7

115.6

0.22

124

(3039443) Prostate specific Ag panel - Serum or Plasma

576

0.74

1.14

1.7

1.6

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.75

1.12

1.1

u/ml

7.9

9.5

—

(3047189) Immunofixation for 24 hour Urine

143

1.54

1.11

1.5

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.96

1.11

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.26

1.10

1.0

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

294

2645

1.12

1.09

1.5

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

113

947

1.20

1.09

3.9

3.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

567

1.26

1.08

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

144

1.53

1.08

8.4

14.2

—

(3033658) Prothrombin time (PT) actual/Normal

881

8339

1.07

4.7

3.9

91.6

89.7

1.36

858

8130

(3021589) Normoblasts [#/volume] in Blood

1541

14849

1.06

1.07

10.5

9.3

e9/l

0.0

0.05

1256

12069

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

286

2574

1.12

1.06

2.9

2.6

ml/min/173m2

65.5

66.9

0.23

124

1009

(3029634) Reagin Ab [Titer] in Serum by VDRL

515

1.27

1.06

2.1

1.9

—

3.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

288

2594

1.12

1.06

2.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

471

1.28

1.05

2.4

2.3

umol/l

8.0

7.5

0.09

348

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

445

1.28

1.05

1.3

—

(3002256) Pathology report gross observation

455

4201

1.09

1.03

1.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.96

1.03

2.1

1.8

pmol/l

27.6

43.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

185

1624

1.15

1.03

3.6

3.4

u/ml

55.1

53.1

0.04

176

1565

(3014148) Varicella zoster virus Ab [Titer] in Serum

474

0.74

1.02

1.3

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

106

1.61

1.02

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

114

1.58

1.02

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

438

1.28

1.02

1.0

1.1

u/ml

0.0

0.4

2.56

110

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1116

0.83

1.02

1.5

1.4

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.92

1.02

6.7

6.0

g/mol

61.4

36.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

229

2041

1.13

1.01

2.9

3.3

pmol/l

4.3

4.5

2.26

200

1821

(3042111) Morphology [Interpretation] in Bone marrow Narrative

546

1.25

1.01

1.5

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

299

1.34

1.00

1.5

1.3

e6/l

134178.0

95952.1

0.15

209

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

214

1.40

0.99

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

802

1.20

0.98

5.9

4.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

134

0.52

0.98

2.3

3.0

ug/l

1.5

1.3

—

125

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.18

0.98

2.4

3.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

148

1284

1.16

0.98

1.8

1.9

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

148

1.49

0.97

2.7

1.7

nmol/l

1.8

7.5

1.08

121

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.95

0.97

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.63

0.97

1.9

2.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.80

0.96

1.1

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

241

1.37

0.96

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

129

1111

1.17

0.94

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

166

1.45

0.94

1.1

1.3

68.2

74.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.62

0.93

2.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

120

0.50

0.93

1.2

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.72

0.92

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.72

0.92

2.8

2.9

—

(3002385) Erythrocyte distribution width [Ratio]

2864

28150

1.06

0.92

20.8

16.5

13.8

13.6

3.24

2803

27537

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

159

1.45

0.91

1.4

1.1

miu/ml

1304.9

1482.7

0.34

159

(3006462) Nitrate [Presence] in Urine

159

1.45

0.91

2.7

3.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

375

1.28

0.91

2.0

1.6

—

(3020650) Glucose [Presence] in Urine

1.60

0.90

1.2

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

102

1.57

0.90

1.0

1.1

93.1

88.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

729

1.20

0.89

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

169

1493

1.14

0.89

1.4

iu/l

26.3

24.6

0.31

148

1243

(4024509)

306

1.31

0.88

1.7

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.91

0.88

1.0

—

(40765096) Chromosome analysis panel by Banding

105

0.48

0.88

1.0

1.1

—

(4211845)

177

1.41

0.88

2.5

3.5

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

2.00

0.87

5.0

5.5

mg/l

4.0

2.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

212

1.37

0.86

2.2

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.67

0.85

1.2

1.1

umol/24h

0.8

0.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.94

0.84

1.0

—

(3015183) Erythrocyte sedimentation rate

191

0.63

0.84

1.1

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

100

854

1.18

0.84

1.9

2.0

mg/l

12.8

11.2

0.35

788

(40762365) Oxygen content in Arterial blood by calculation

1.76

0.83

1.9

2.6

ml/dl

15.7

14.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

318

1.29

0.83

4.2

3.6

—

(1002224) Polysomnography panel

113

1305

0.86

0.83

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

257

2339

1.11

0.83

1.2

iu/ml

112.0

148.3

0.78

848

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

662

1.20

0.82

4.3

3.7

56.3

57.4

0.35

662

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

240

1.34

0.82

2.2

1.8

—

(3020874) Milk IgE Ab [Units/volume] in Serum

223

1.35

0.81

1.0

1.1

u/ml

0.2

2.0

1.08

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.55

0.81

3.1

2.2

e6/l

2116.7

21310.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

155

1.42

0.81

2.0

2.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.70

0.80

2.4

3.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

215

1.35

0.80

1.4

1.5

u/l

15.3

13.6

0.33

206

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

122

1.48

0.80

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

692

1.19

0.80

4.3

3.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

365

1.26

0.79

6.4

7.8

mmol/l

7.1

7.3

0.11

307

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

114

1.49

0.79

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.79

0.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

519

1.22

0.79

1.2

u/l

25.4

40.2

0.64

446

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

251

1.32

0.78

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

1.56

0.78

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

208

1.35

0.77

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

261

1.31

0.76

2.1

1.5

—

(4035726)

306

2823

1.09

0.76

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

440

1.23

0.75

1.1

g/l

1.6

1.5

0.78

393

(4198724)

183

1.37

0.75

2.0

2.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

244

2668

0.91

0.75

4.1

3.7

mmol/l

1.2

0.25

213

2318

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.60

0.74

4.3

7.8

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.08

0.74

1.0

1.5

umol/24h

358.0

346.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

116

1.47

0.74

2.2

2.1

ug/l

50.7

66.4

0.58

111

(3003181) Sodium [Moles/volume] in Urine

569

1.20

0.74

1.5

1.4

mmol/l

62.8

64.1

0.09

465

(4306422)

487

1.21

0.73

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

109

950

1.15

0.73

4.0

3.9

mmol/l

3.9

0.00

104

884

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.00

0.72

1.0

1.3

u/l

12.6

14.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

718

1.17

0.72

4.8

3.4

mg/l

28.8

26.4

0.27

460

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.80

0.72

1.0

1.3

mmol/l

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

110

0.54

0.72

1.0

1.1

—

(1616796) Gas panel - Central venous blood

757

1.17

0.71

5.0

3.6

—

(3011648) Oxygen content in Venous blood

274

1.28

0.69

1.9

3.1

11.7

11.2

0.32

274

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

117

1030

1.14

0.69

2.2

2.3

g/l

0.8

0.9

0.10

104

897

(4038314)

1.85

0.68

1.4

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

227

2079

1.10

0.68

1.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

311

1.26

0.67

1.2

1.1

u/l

59.1

59.2

0.01

216

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

102

1.47

0.67

1.0

1.3

97.3

86.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

384

1.23

0.66

1.5

1.4

e6/l

3165.4

1683.1

1.19

277

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.59

0.65

1.3

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

336

3140

1.08

0.64

2.8

2.4

u/l

36.7

37.9

0.12

293

2688

(3023511) Choriogonadotropin [Units/volume] in Urine

765

1.15

0.64

1.3

1.4

—

(40768795) Lymph node Pathology biopsy report

314

1.24

0.63

1.4

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.63

0.62

1.3

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

208

1.30

0.62

5.6

6.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

147

1.36

0.61

1.1

—

(44813793)

226

1.29

0.61

1.1

1.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

139

1.37

0.60

1.3

1.8

umol/l

25.8

30.5

2.11

134

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

2.4

—

3.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

768

0.86

0.59

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

192

1.30

0.59

1.6

1.4

u/l

5.1

7.6

1.41

164

(3043238) Trisomy 21 risk [Likelihood] in Fetus

789

0.86

0.59

1.4

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.44

0.59

1.2

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

650

1.16

0.58

3.1

3.4

u/ml

1435.6

711.5

0.30

597

(40759836) Histone Ab [Presence] in Serum by Immunoblot

237

1.27

0.58

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

237

1.27

0.58

1.0

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

127

1141

1.12

0.58

3.7

3.4

u/ml

1319.2

3668.8

0.44

111

963

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.72

0.57

1.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

184

1.31

0.57

1.8

2.5

umol/l

19.1

26.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

238

1.26

0.56

1.0

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

680

1.15

0.56

1.7

2.2

nmol/l

1.0

0.8

1.17

569

(3005033) Fetal Nuchal fold Thickness US

764

0.86

0.56

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

347

1.21

0.56

1.3

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

1.54

0.55

1.1

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

239

1.26

0.55

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

239

1.26

0.55

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.46

0.54

1.1

1.2

ug/l

245.0

407.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

151

1.33

0.53

1.7

2.9

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

240

1.25

0.53

1.0

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

102

910

1.12

0.53

2.2

g/l

0.0

0.67

840

(3032868) Hemoglobin electrophoresis panel in Blood

1.54

0.53

1.3

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

313

1.22

0.53

1.9

2.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

855

1.13

0.52

2.2

g/l

0.0

0.00

789

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

385

3647

1.06

0.52

1.3

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.50

0.51

1.0

1.2

umol/24h

3.0

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

640

0.86

0.51

3.3

3.1

nmol/l

0.8

0.07

486

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

126

1.35

0.51

2.3

3.3

au/ml

53.5

61.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

847

1.12

0.51

2.2

g/l

0.0

0.00

788

(3025130) Human papilloma virus identified in Specimen

417

1.18

0.49

1.9

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

104

935

1.12

0.49

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

207

1.26

0.49

2.2

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

144

0.69

0.49

1.6

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.56

0.49

13.7

12.8

mmol/l

4.8

6.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.52

0.48

1.1

1.2

—

(3036603) Volume of Urine

208

1.25

0.47

1.7

1.4

1981.9

1979.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

550

1.15

0.47

1.3

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

506

0.85

0.47

1.3

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

281

1.21

0.47

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

137

1.32

0.47

1.3

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.47

0.47

4.1

8.1

—

(3045788) Cell count panel - Pleural fluid

300

1.20

0.46

1.7

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

495

1.15

0.46

1.2

u/ml

7.4

4.1

0.41

161

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.43

0.46

5.1

8.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

552

1.14

0.45

1.3

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

164

0.73

0.45

1.0

1.1

—

10.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

183

1.26

0.44

2.5

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

183

1.26

0.44

2.5

1.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

157

1.28

0.43

1.1

—

5.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.66

0.42

1.3

1.4

ug/l

9.6

8.8

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.56

0.42

1.0

1.3

—

5.9

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.40

0.42

1.1

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.52

0.41

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.41

0.0

3.4

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.41

0.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

194

1816

1.07

0.41

1.2

1.3

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.5

—

15.7

—

(3042517) Benzodiazepines panel - Urine

1.47

0.40

1.4

2.8

—

(3024869) Neuronal Ab [Presence] in Serum

1.33

0.40

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

115

1055

1.09

0.40

1.6

1.4

u/l

9.4

9.2

0.07

838

(3008295) Osmolality of Serum or Plasma

362

1.16

0.39

1.4

1.5

mosm/kgh2o

279.4

280.7

0.12

273

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.39

0.0

1.3

—

3852.1

—

(3017569) Oxygen content in Arterial blood

160

1.25

0.38

1.9

2.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

108

991

1.09

0.38

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.34

0.38

1.7

2.4

—

(3044007) Cell count panel - Peritoneal fluid

1.35

0.37

3.8

2.3

—

(40761536) Microorganisms panel - Urine sediment

273

2872

0.95

0.37

4.7

3.9

—

(3024932) HLA-DR beta [Type]

112

0.71

0.37

1.4

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

104

954

1.09

0.37

1.4

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

383

1.15

0.37

1.1

—

(3024471) HLA-A [Type]

114

0.70

0.37

1.1

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

161

1.24

0.37

1.6

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

116

1.29

0.37

1.2

1.1

u/ml

4.5

2.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

469

1.13

0.36

1.5

1.4

ug/l

2.3

3.9

1.94

425

(3003694) ABO and Rh group [Type] in Blood

948

9705

0.97

0.35

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

171

1.23

0.35

2.7

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

171

1.23

0.35

2.7

2.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

479

1.13

0.35

1.2

u/ml

4.7

4.9

0.03

213

(3014599) Egg white IgE Ab [Units/volume] in Serum

217

1.20

0.35

1.0

1.1

u/ml

0.4

3.9

0.88

(3028308) Erythrocytes [#/volume] in Pleural fluid

338

1.16

0.35

1.5

1.4

e6/l

25032.1

82221.7

1.36

199

(3006270) Folate [Moles/volume] in Blood

282

1.17

0.35

1.4

1.1

nmol/l

356.2

383.6

0.26

250

(3013166) Neutrophils/100 leukocytes in Synovial fluid

108

1.30

0.35

1.1

1.3

42.2

53.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.40

0.35

1.0

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.40

0.35

20.0

9.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.37

0.34

1.2

1.3

—

(3011288) Drugs identified in Urine by Screen method

115

1065

1.08

0.34

4.5

3.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

549

5667

0.96

0.34

3.0

ug/l

0.9

0.8

0.69

386

3738

(4034850)

114

1056

1.08

0.34

11.9

9.8

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

145

1.24

0.33

1.6

1.8

117.1

146.1

0.89

136

(3022493) Free Hemoglobin [Mass/volume] in Plasma

136

1.25

0.33

1.4

4.0

mg/l

178.5

71.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

768

1.10

0.33

1.9

2.4

ug/min

105.3

81.0

0.27

480

(3014891) Appearance of Pleural fluid

1.30

0.33

1.8

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.68

0.33

5.8

3.0

—

(3000764) Benzodiazepines [Presence] in Urine

168

1583

1.06

0.32

2.8

2.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

486

0.88

0.31

1.0

u/ml

2.4

2.2

0.09

222

(3023487) Leukocytes [#/volume] in Peritoneal fluid

110

1.27

0.31

3.2

2.5

e6/l

634.8

756.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

370

1.14

0.31

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.35

0.31

1.1

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

283

0.85

0.30

1.8

1.6

mmol/l

7.6

7.7

0.07

167

(3045716) Anion gap in Serum or Plasma

153

0.78

0.30

2.8

2.4

mmol/l

9.7

9.2

—

121

(3014765) Yersinia sp identified in Stool by Organism specific culture

107

997

1.08

0.29

1.2

1.1

—

(3034426) Prothrombin time (PT)

106

0.75

0.29

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

108

1007

1.07

0.29

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

708

1.09

0.28

1.3

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

130

1.23

0.28

1.0

—

(3027008) Opiates [Presence] in Urine

168

1591

1.06

0.28

2.7

2.1

—

(4268621)

336

1.13

0.28

2.2

2.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

517

1.10

0.28

1.4

1.5

nmol/l

0.3

0.4

1.83

412

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.25

0.27

1.0

1.2

—

131.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

102

952

1.07

0.27

2.1

2.2

g/l

37.6

37.7

0.10

820

(3028300) Cannabinoids [Presence] in Urine

168

1595

1.06

0.27

2.8

2.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

196

1.17

0.27

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

290

1.14

0.27

1.2

1.5

39.9

32.1

0.50

185

(40768793) Breast Pathology biopsy report

719

0.92

0.27

1.4

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1008

0.93

0.26

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

500

1.10

0.26

1.2

—

(3042733) HLA Ab [Presence] in Serum

104

1.25

0.26

4.8

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.19

0.26

1.0

1.3

106.9

107.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.26

0.26

1.1

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

157

1654

0.95

0.26

1.2

1.1

titre

15.1

184.4

—

(40757373) Influenza virus identified in Isolate

0.70

0.26

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

386

1.12

0.26

1.3

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

102

956

1.07

0.25

1.8

nmol/l

39.1

40.3

0.23

927

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

483

1.10

0.25

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.25

0.24

1.8

1.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

126

0.79

0.24

1.2

g/l

—

0.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

139

1319

1.06

0.24

1.7

1.6

mu/l

344.2

298.5

0.66

126

1198

(44806071)

1.32

0.23

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.28

0.23

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

505

1.09

0.23

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

168

0.83

0.22

1.8

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.25

0.22

1.8

2.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

200

1.15

0.22

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

200

1.15

0.22

1.2

3.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

238

1.14

0.22

1.7

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.22

0.22

1.8

1.4

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

8.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

5.9

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3036180) Methadone [Presence] in Urine

0.00

0.21

0.0

2.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

387.9

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.1

—

1.4

—

(3016879) Cocaine [Presence] in Urine

155

1482

1.05

0.21

2.9

2.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

440

1.09

0.21

1.7

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

822

0.94

0.21

1.9

1.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.16

0.21

1.2

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3006653) Thiamine [Moles/volume] in Blood

173

1.16

0.20

1.5

1.3

nmol/l

144.3

133.5

0.51

173

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.25

0.20

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.25

0.20

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.25

0.20

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.25

0.20

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

594

0.92

0.20

1.1

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

123

0.81

0.20

1.0

—

(3024263) Appearance of Synovial fluid

164

1.16

0.20

1.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.20

0.0

1.3

—

(3000285) Sodium [Moles/volume] in Blood

1.25

0.20

1.2

1.0

—

(3004775) Volume in Urine collected for unspecified duration

259

1.12

0.20

1.6

2.3

797.3

625.6

1.47

175

(3025018) Bordetella pertussis Ab [Titer] in Serum

202

1.14

0.20

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

176

0.85

0.19

1.7

1.8

—

(3051101) Glucose [Moles/volume] in Cord blood

1.18

0.19

4.8

5.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

203

1.13

0.19

1.0

ng/l

727.5

683.2

0.20

127

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.21

0.18

2.1

2.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.19

0.18

1.1

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.17

0.17

1.6

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

329

1.10

0.17

4.3

4.8

u/ml

18.2

80.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

163

0.86

0.17

1.0

1.1

—

(40768441) Liver Pathology biopsy report

243

1.11

0.17

1.3

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

763

0.94

0.17

2.5

2.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.76

0.17

1.2

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

205

1.12

0.17

1.0

ng/l

290.6

317.7

0.26

132

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

205

1.12

0.17

1.0

ng/l

39.7

45.4

0.36

128

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

541

5314

1.02

0.16

1.5

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

158

1.14

0.16

1.0

1.1

85.5

91.2

0.27

123

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.13

0.16

1.4

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

206

1.12

0.16

1.1

ratio

1.1

1.0

—

(3027944) Amphetamines [Presence] in Urine

162

1565

1.04

0.15

1.9

2.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

168

1.13

0.15

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

207

1.11

0.15

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.10

0.15

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

169

1638

1.03

0.14

4.6

3.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

665

1.05

0.14

1.2

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

499

1.06

0.14

3.1

3.9

u/ml

45.4

33.4

0.28

485

(3024891) Influenza virus A+B Ag [Presence] in Specimen

902

1.04

0.13

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

113

1.15

0.13

3.1

2.8

umol/l

34.8

28.9

—

(4133840)

1.17

0.13

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

296

1.08

0.13

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

123

1.14

0.12

1.1

1.0

—

(4094501)

836

1.04

0.12

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

935

0.96

0.11

1.5

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

199

0.90

0.11

1.6

1.5

u/l

6.7

6.6

0.01

(3045142) Bone marrow Pathology biopsy report

376

1.06

0.11

1.4

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

147

0.88

0.11

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

934

0.96

0.11

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

932

0.96

0.10

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

932

0.96

0.10

1.5

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

423

0.95

0.10

1.3

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

382

3765

1.02

0.10

1.7

—

(3004451) EKG impression Narrative

154

1.10

0.10

1.1

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.14

0.10

1.0

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.14

0.10

1.8

2.1

—

(3020393) Adenovirus Ag [Presence] in Stool

1.14

0.10

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.11

0.09

1.6

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

408

1.05

0.09

2.6

2.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.09

0.09

1.0

—

(21494434) Karyotype in Bone marrow

291

1.07

0.09

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.04

0.09

1.0

1.4

ng/l

92.8

102.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

145

1.10

0.09

1.1

iu/ml

163.6

198.3

0.26

145

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

912

1.03

0.09

1.6

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.09

0.08

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

449

1.05

0.08

1.2

1.3

mmol/l

7.3

7.2

0.07

326

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

253

1.07

0.08

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

257

0.93

0.08

1.9

2.1

u/field

1.1

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

117

1200

0.97

0.08

1.5

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.08

0.08

1.1

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

156

1.09

0.08

1.9

2.4

ug/l

24.3

220.8

0.67

141

(3035933) Granulocytes/100 leukocytes in Blood

127

1.10

0.07

1.3

1.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

0.83

0.07

3.3

6.5

57.2

72.7

—

(4281824)

323

1.05

0.07

1.3

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

109

1064

1.03

0.07

1.4

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

392

1.05

0.07

2.0

2.1

32.7

32.5

0.07

387

(3010421) pH of Blood

906

1.03

0.07

6.5

4.2

7.4

0.16

763

(3022689) Creatine [Moles/volume] in Urine

1.06

0.07

1.3

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

157

1.08

0.07

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.02

0.07

1.3

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.87

0.06

1.3

1.5

10.7

25.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

779

1.03

0.06

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

207

1.06

0.06

1.1

1.7

—

(3012501) Base excess in Blood by calculation

771

1.03

0.05

5.7

4.4

mmol/l

2.7

2.6

0.02

517

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

495

1.03

0.05

1.8

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

242

0.95

0.05

1.1

1.4

pmol/l

54.6

182.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

115

1131

1.02

0.04

1.4

1.3

miu/ml

215.9

225.8

0.12

519

(1001926) Buprenorphine [Presence] in Urine by Screen method

123

1249

0.98

0.04

3.2

2.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

338

3353

1.01

0.04

3.8

3.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

543

0.98

0.04

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

210

0.95

0.03

12.7

nmol/l

846.9

827.1

0.06

202

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

185

1832

1.01

0.03

1.5

—

(40768806) Pleura Pathology biopsy report

330

0.97

0.03

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

241

1.04

0.02

1.6

1.2

—

(3000012) Reticulocyte production index

158

0.95

0.02

2.1

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

590

0.98

0.02

3.0

3.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

222

1.04

0.02

1.0

1.1

iu/ml

3.0

11.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

819

0.99

0.01

1.6

1.9

iu/l

3.4

4.5

0.54

286

(3044941) Cell count panel - Synovial fluid

513

1.01

0.01

1.5

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

154

1.04

0.00

1.4

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

228

1.01

0.00

1.4

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

135

1.04

0.00

1.1

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

214

0.98

0.00

20.0

17.4

nmol/l

1416.1

1459.2

0.09

207

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

224

0.98

0.00

1.3

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

716

1.01

0.00

3.4

2.4

15.8

16.2

0.47

351

(3012441) Differential panel - Pleural fluid

323

0.99

0.00

1.6

1.5

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3032641) Amino acids panel - Urine

0.00

0.0

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.91

0.00

1.4

1.7

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

0.91

0.00

1.4

1.5

0.2

2.7

—

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.97

0.00

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.91

0.00

2.0

2.1

umol/l

21.8

18.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

3.2

—

58.7

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.2

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

3776.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

13.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_PERFORATION and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_PERFORATION	1.099 [0.99, 1.22]	0.071
Birth year	0.996 [0.99, 1.0]	0.37

During the follow-up period (1.1.1998 — 31.12.2019), 1840 out of 14921 females with H8_PERFORATION died.

Males

Parameter	HR [95% CI]	p-value
H8_PERFORATION	1.182 [1.07, 1.31]	0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 2140 out of 16352 males with H8_PERFORATION died.

Mortality risk

Mortality risk for people of age

years, who have H8_PERFORATION.

N-year risk	Females	Males
1	0.103%	0.211%
5	0.734%	1.322%
10	1.628%	3.392%
15	2.984%	6.549%
20	5.382%	11.176%

Relationships between endpoints

↥

Index endpoint: H8_PERFORATION – Perforation of tympanic membrane

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Perforation of tympanic membrane

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints